GSK MMR vaccine, Priorix, receives FDA approval
by Press Release from Outbreak News Today on (#602CM)
NewsDesk @bactiman63 GSK today announced that the US Food and Drug Administration (FDA) has approved Priorix (Measles, Mumps and Rubella Vaccine, Live) for active immunisation for the prevention of measles, mumps and rubella (MMR) in individuals 12 months of age and older. Priorix is currently licenced in more than 100 countries worldwide, including all European countries, Canada, Australia [...]
The post GSK MMR vaccine, Priorix, receives FDA approval appeared first on Outbreak News Today.